AP-HP article on METAglut1, a simple blood test that allows the diagnosis of Glut1DS Nous sommes heureux que les résultats de l’étude de validation de […]
March. 31st 2021 – Last inclusion of a patient in METAglut1 validation study The METAglut1 study is a prospective study to validate the diagnostic performance of […]
Jan. 31st 2020 – First inclusion of a retrospective patient in the validation study of the METAglut1™ test in Germany Approximately 50 German patients will be […]
Sept. 5th 2018– Dietmar Hopp Metabolic Center is now equipped with METAglut1 test to conduct a validation study in Germany Universität Heidelberg, Stoffwechsellabor, a leading center […]
The METAglut1 study is a prospective study to validate the diagnostic performance of the METAglut1 test in patients clinically compatible with GLUT1 Glucose Deficiency Syndrome (GLUT1-DS) […]
Metafora biosystems receives exceptional reimbursement for new blood test to help diagnose De Vivo disease METAglut1 test enables early detection of this rare under-diagnosed disease A […]
The METAglut1 test developed by METAFORA to diagnose the GLUT1 deficiency syndrome through a simple blood sample has been CE marked starting February 2017. This test […]